Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

JW Pharmaceutical Corporation imbali icatshulwa imbali

Ixabiso lentengoJW Pharmaceutical Corporation e Laphumelela yaseMzantsi Korea ishati ukususela ekuqaleni kokuthengisa. JW Pharmaceutical Corporation ixabiso lembali e Won ukususela ngoku 2005.
Yongeza kumajethijethi
Ukongezwa kumajethi

JW Pharmaceutical Corporation zitshintshi e Laphumelela yaseMzantsi Korea imbali yamanani, ishati ukususela ekuqaleni kokuthengisa

Iindleko zezabelo JW Pharmaceutical Corporation zatshintshile zibe ngu-+0.16% ngeveki. Ngenyanga edlulileyo, intengo yesabelo se-JW Pharmaceutical Corporation yatshintsha ngo-+4.22%. Ukutshintsha kwintengo yesabelo se-001065.KS kwikota yokugqibela bekuyi-+1.1%. Ngonyaka kunye neminyaka emithathu, ixabiso lezabelo ze-JW Pharmaceutical Corporation zatshintshela ku--16.406% nakwi-+25.64%, ngokulandelana.

Bonisa:
Ukuze

JW Pharmaceutical Corporation Won ixabiso lembali

 
Umhla Izinga
2023 Ku 29 450 Ukuze 33 100 KRW
2022 Ku 31 300 Ukuze 38 650 KRW
2021 Ku 28 350 Ukuze 63 200 KRW
2020 Ku 17 250 Ukuze 102 000 KRW
2019 Ku 23 750 Ukuze 31 250 KRW
2018 Ku 22 150 Ukuze 30 850 KRW
2017 Ku 21 617.600 Ukuze 28 333.300 KRW
2016 Ku 21 049.600 Ukuze 33 064.200 KRW
2015 Ku 10 527.100 Ukuze 27 004.300 KRW
2014 Ku 9 720.670 Ukuze 10 810.400 KRW
2013 Ku 8 676.570 Ukuze 12 579 KRW
2012 Ku 8 065.710 Ukuze 10 872.900 KRW
2011 Ku 8 886.590 Ukuze 18 300.400 KRW
2010 Ku 9 865.620 Ukuze 12 463.800 KRW
2009 Ku 5 403.320 Ukuze 12 722.300 KRW
2008 Ku 4 818.380 Ukuze 11 223.400 KRW
2007 Ku 11 223.400 Ukuze 29 264.700 KRW
2006 Ku 13 201 Ukuze 17 620.500 KRW
2005 Ku 15 496.800 Ukuze 18 596.200 KRW

Iindleko zezabelo JW Pharmaceutical Corporation

YezeMali JW Pharmaceutical Corporation